ROKIT Healthcare to Enable Innovation in Treatment of Diabetes Foot and Osteoarthritis Combining AI and 3D Bioprinting on Google Cloud
- Medical platform that converges Cloud, AI, and 3D bioprinting expected to dramatically improve treatment rate and medical access. SEOUL, South Korea, Aug. 12, 2022 /PRNewswire/ -- ROKIT Healthcare, a company specializing in bio-healthcare, today announced it will provide a hyper-personalized medical platform that uses 3D bioprinting and AI technology built on Google Cloud, to innovate the treatment of osteoarthritis...
Seegene reports H1 2022 financial results
H1 revenue fell 11% YoY to KRW 579.9 billion, operating profit down 37% to KRW 212.7 billion Decline due to drop in Q2 sales amid reduced PCR testing volume Sales of non-COVID products and PCR instruments increased in H1; Company launches STARlet-AIOS to strengthen sales foundation Seegene to expand In-life...
WeTrade Group Inc. Announces US$50 Million Sales of Monkeypox Virus Test Kits to Parkway Medical Limited
BEIJING, Aug. 12, 2022 /PRNewswire/ -- WeTrade Group Inc. ("Wetrade" or the "Company") (NASDAQ: WETG), an emerging growth company engaged in the business of providing software-as-a-services (SAAS) and cloud intelligent systems for micro-businesses, today announced the Company has entered into a sales agreement (the "Agreement") on August 11, 2022 with Parkway Medical Limited ("Parkway Medical") to sell monkeypox virus...
JIN-A02, A Novel 4th Generation EGFR TKI selected for the European Thoracic Oncology Platform – A First for Korean Pharma.
SEOUL, South Korea, Aug. 12, 2022 /PRNewswire/ -- J INTS BIO announced that the pre-clinical data of its novel, orally administered 4th generation EGFR TKI 'JIN-A02' was presented at the 2022 IASLC World Conference on Lung Cancer in Vienna, Austria on 8th August, at the official session "Overcoming Resistance to EGFR Inhibitors". J INTS...
WuXi ATU Announces Licensing Agreement with Janssen for TESSA™ Technology
PHILADELPHIA, Aug. 12, 2022 /PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced a licensing agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson ("Janssen"). Under this agreement, WuXi ATU will license to Janssen its TESSA™ technology, a high-performance system that can produce 10 times more...
Top Organizations Lauded with Prestigious Industry Recognition by Frost & Sullivan for Best-in-Class Performance
17 Awards are set to be presented at Frost & Sullivan's 10th Virtual Awards Ceremony, which will be broadcasted live on YouTube at 1730 hours (GMT +8), 17 August 2022. SINGAPORE, Aug. 11, 2022 /PRNewswire/ -- Frost & Sullivan Best Practices Awards in Asia-Pacific celebrates a giant milestone with the highly anticipated 10th virtual awards ceremony. The...
Menarini Group’s Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer
Elacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from 2L and 3L ER+/HER2- advanced or metastatic breast cancer Submission supported by results from the pivotal Phase 3 EMERALD study of elacestrant showing statistically significant efficacy over current standard-of-care (SOC) medications for both the overall study population and...
Zepp Health Corp. to Report Second Quarter 2022 Financial Results on August 25, 2022
Earnings Call Scheduled for 8:00 a.m. ET on August 25, 2022 BEIJING, Aug. 11, 2022 /PRNewswire/ -- Zepp Health Corp. ("Zepp Health" or the "Company") (NYSE: ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its second quarter 2022 unaudited financial results before the market open on Thursday, August 25, 2022. Management will hold...
Everest Medicines Announces Regulatory Update and Strategic Partnership for Xerava™ in Taiwan
Taiwan FDA accepts New Drug Application for Xerava for treatment of cIAI Everest enters into strategic partnership with TTY Biopharm for the commercialization of Xerava in Taiwan SHANGHAI, Aug. 11, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia...
Deep Longevity Selected by Kickstart as One of the Most Promising Start-ups in the World Discussing Proof of Concepts with Big Insurance and Health and Wellbeing Companies
Its FuturSelf mind journey offering at https://futurself.ai continues to gain traction with close to 30,000 registered users HONG KONG, Aug. 10, 2022 /PRNewswire/ -- Endurance RP Limited's ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) wholly owned subsidiary Deep Longevity, Inc, a Hong Kong-based AI innovator and a leading provider of deep biomarkers of...
